![Kostia Janssens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kostia Janssens
Corporate Officer/Principal bij Epitopoietic Research Corp.
Actieve functies van Kostia Janssens
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Epitopoietic Research Corp.
![]() Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Corporate Officer/Principal | - | - |
Loopbaan van Kostia Janssens
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Epitopoietic Research Corp.
![]() Epitopoietic Research Corp. BiotechnologyHealth Technology Part of ERC-Belgium SA, Epitopoietic Research Corp. is a clinical stage emerging bio-pharmaceutical company based in Pasadena, CA. The company is developing a safe, highly effective approach for the treatment of cancer using immunotherapy, with particular focus on the treatment of patients with glioblastoma multiforme (GBM), the most deadliest form of brain cancer, using its patented Gliovac/ERC1671 vaccine. The company was founded by Bernard Alliaume, Apostolos Stathopoulos. Apostolos Stathopoulos has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Kostia Janssens
- Ervaring